These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34289402)

  • 1. Microdialysis sampling to monitor target-site vancomycin concentrations in septic infants: a feasible way to close the knowledge gap.
    Schroepf S; Burau D; Muench HG; Derendorf H; Zeitlinger M; Genzel-Boroviczény O; Adam D; Kloft C
    Int J Antimicrob Agents; 2021 Oct; 58(4):106405. PubMed ID: 34289402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug combinations and impact of experimental conditions on relative recovery in in vitro microdialysis investigations.
    Burau D; Petroff D; Simon P; Ehmann L; Weiser C; Dorn C; Kratzer A; Wrigge H; Kloft C
    Eur J Pharm Sci; 2019 Jan; 127():252-260. PubMed ID: 30391402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose regimen for vancomycin not needing serum peak levels?
    Tan WH; Brown N; Kelsall AW; McClure RJ
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal vancomycin continuous infusion: still a confusion?
    Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
    Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series.
    Bidu NS; Fernandes BJD; Dias EJC; Filho JNC; Bastos REA; Godoy ALPC; Azeredo FJ; Pedreira JNR; Couto RD
    Curr Pharm Biotechnol; 2019; 20(4):346-351. PubMed ID: 30892160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to use vancomycin optimally in neonates: remaining questions.
    Jacqz-Aigrain E; Leroux S; Zhao W; van den Anker JN; Sharland M
    Expert Rev Clin Pharmacol; 2015; 8(5):635-48. PubMed ID: 26289222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.
    Frymoyer A; Stockmann C; Hersh AL; Goswami S; Keizer RJ
    J Pediatric Infect Dis Soc; 2019 May; 8(2):97-104. PubMed ID: 29294072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
    Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
    Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
    Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
    Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
    BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
    Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections via In Vivo Microdialysis.
    Housman ST; Bhalodi AA; Shepard A; Nugent J; Nicolau DP
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):381-8. PubMed ID: 26429605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.
    Hill LF; Turner MA; Lutsar I; Heath PT; Hardy P; Linsell L; Jacqz-Aigrain E; Roilides E; Sharland M;
    Trials; 2020 Apr; 21(1):329. PubMed ID: 32293527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
    Abraham J; Sinnollareddy MG; Roberts MS; Williams P; Peake SL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2019 Feb; 53(2):137-142. PubMed ID: 30296581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.